'Time Saved' As a Demonstration of Clinical Meaningfulness and Illustrated Using the Donanemab TRAILBLAZER-ALZ Study Findings.
J Prev Alzheimers Dis
; 10(3): 595-599, 2023.
Article
in En
| MEDLINE
| ID: mdl-37357301
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Alzheimer Disease
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Humans
Language:
En
Journal:
J Prev Alzheimers Dis
Year:
2023
Type:
Article